Q-omics provides the consensus-scored MIR548AW profile across patient tissues and cancer cell-line models. MIR548AW expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in HNSC. Additionally, MIR548AW RNA expression shows 4,780 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight HNSC, and STAD as cancer lineages where MIR548AW shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.